PivotAsia Biotech Latest Deals, Data, and Policy

Why Fentanyl May Decide the Success of the Trump–Xi Meeting

New Episode: What a Series investor sees AI Use Differs in the US and China

Our latest podcast guest Ray Yang of Marathon Capital and previously Northern Light Capital shares his key observations about AI health applications in the United States and China, and how a humble Huimingbao is making strides providing much-needed coverage to innovative oncology and CAR-T therapies.

Special Edition: What a Weeklong Trip Reveals about U.S.-China Biotech Competition

China’s biotech hub Shanghai is buzzing, yet the excitement is focused on breakthrough science and local rivalry.

China Biotech’s Summer Surge: The Latest Deals, Data, and Policy Moves

Plus: Policy Watch and What to Watch